Skip to Content

Amyloid Antibodies as Future Treatment for Early Alzheimer’s Disease?

More antibodies targeting amyloid have been developed, and one of the raising questions is if they are usable in treating Alzheimer’s disease. In this MEDtalk, Consultant Neurologist Kristian Steen Frederiksen presents studies investigating the efficacy and safety of the drug lecanemab.

Kristian Steen Frederiksen

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top